Reflections on a Specialist HIV Menopause Service

Experiences of Managing Menopause in Women Living With HIV

Mimie Chirwa; Neda Taghinejadi; Gabrielle Macaulay; Sundhiya Mandalia; Claire Bellone; Nicholas Panay; Roberta Brum; Nneka Nwokolo


HIV Medicine. 2022;23(4):426-433. 

In This Article


Menopausal hormone therapy was acceptable and uptake of treatment was high in this cohort of predominantly black, symptomatic women living with HIV. The long delay from onset of symptoms to referral and review in the clinic highlights the need for menopause awareness among HIV clinicians, GPs and women living with HIV themselves. Given the rate of comorbidities in this group, clear referral pathways for integrated care with mental health teams, gynaecologists and medical specialities appears to be a fundamental aspect when planning for specialist menopause services. Many of the issues highlighted in this cohort are also reflected in the burgeoning menopause discourse among menopausal women in the general UK population.

Further research is necessary to better understand the interaction between menopause and HIV with regard to symptom presentation, associated comorbidities and clinical significance and ideal management of DDIs between some antiretroviral drugs and MHT. It is also important that data are gathered on the risks and benefits of MHT for women living with HIV, for both short- and long-term use.